Comparar métodos

	Estudio de Asociación del Epigenoma Completo Multi-ómico	Análisis de eQTL
Campo	Bioinformática	Bioinformática
Familia	Process / pipeline	Process / pipeline
Año de origen	2011 (EWAS foundation); multi-omics integration ~2015–2020	2001 (term coined); widely adopted after 2005
Autor original	Rakyan, Down, Balding & Beck (EWAS framework); multi-omics integration extended by multiple groups (~2015–2020)	Ritsert C. Jansen & Jan-Peter Nap
Tipo	Integrative association study	Association mapping method
Fuente seminal	Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541.	Jansen, R. C., & Nap, J.-P. (2001). Genetical genomics: the added value from segregation. Trends in Genetics, 17(7), 388–391.
Alias	multi-omics EWAS, integrative EWAS, multi-layer epigenome-wide association, multi-omics epigenomic integration	eQTL mapping, expression QTL analysis, transcriptomic QTL analysis, eQTL study
Relacionados	4	6
Resumen	A multi-omics epigenome-wide association study (multi-omics EWAS) systematically scans the entire epigenome — typically DNA methylation at CpG sites — for associations with a phenotype of interest, then integrates findings across additional omics layers such as transcriptomics, genomics, proteomics, or metabolomics. By linking epigenetic variation to molecular changes at multiple biological levels simultaneously, this approach identifies regulatory mechanisms and biomarkers that single-omics EWAS cannot resolve.	eQTL analysis identifies genomic loci (variants, typically SNPs) whose genotype statistically associates with variation in the expression level of one or more genes. By jointly profiling DNA-level variation and RNA-level expression in the same individuals, eQTL studies decode the regulatory grammar of the genome — revealing which variants control how much a gene is transcribed, in which tissues, and under what conditions.